Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer (Q27853180)
Jump to navigation
Jump to search
scientific article published on 14 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer |
scientific article published on 14 July 2015 |
Statements
1 reference
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer (English)
1 reference
14 July 2015
0 references
113
0 references
2
0 references
199-203
0 references